Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    FDA and EMA Global labeling challenges faced in day-to-day operations

    View: 124

    Website http://bit.ly/2kJHygG | Want to Edit it Edit Freely

    Category FDA EMA regulation, FDA Labeling regulation, EMA Labeling regulation, Pharma Labeling, labeling records, XML labeling, Structured Product Labeling

    Deadline: March 09, 2017 | Date: March 09, 2017

    Venue/Country: New Hyde Park, U.S.A

    Updated: 2017-02-13 18:54:37 (GMT+9)

    Call For Papers - CFP

    Overview:

    Pharmaceutical companies must manage the process of designing and creating product labels that meet regulatory requirements. This includes product-labeling documents such as Packet Inserts (PIs), Summaries of Product Characteristics (SmPCs) and Core Data Sheets (CDSs). The large number of product strengths, dosage forms and product presentations results in a large number of labeling records that must be maintained and kept synchronized.

    The FDA and EMA are implementing a set of rules for the electronic submission of labeling content. The FDA labelling regulation requires companies to submit XML labeling content in Structured Product Labeling (SPL) format. The EMA labelling regulation requires companies to submit product information documents in QRD-compliant format.

    Companies in the regulated life sciences industries must develop and implement systems and processes that will ensure compliance with these standards for their global labeling content. They must also take a longer-term view as to how best to minimize the complexity and cost of doing so.

    In this webinar, we will discuss ways to overcome these pharma labelling regulatory challenges and understand how companies in the life sciences industries are doing so through best practices.

    Why Should You Attend:

    You should attend this webinar if you are responsible for designing, creating or implementing product labels, or maintaining labeling records.

    You should also attend if you are responsible for developing and maintaining the systems required for submitting XML labeling content in Structured Product Labeling (SPL) format.

    Finally, you should attend if you are responsible for ensuring compliance with labeling requirements for your company.

    Areas Covered in this Webinar:

    Product labeling background and rationale

    Requirements for complying with FDA and EMA requirements for labeling

    Converting Word documents into XML and SPL format

    The essential labeling materials that are covered

    Organizing and maintaining labeling records efficiently and effectively

    Inspection of labeling records

    Learning Objectives:

    Learn what product labeling material is subject to FDA and EMA regulation

    Understand the specifics of FDA and EMA regulations for product labeling and how to comply

    Learn how to establish and maintain a well-organized system for product labeling, and provide quality assurance for the data included

    Learn the importance of developing a consistent system for locating labeling records, and preparing them for regulatory inspection

    Learn about best practices and industry standards

    Who Will Benefit:

    Those responsible for Designing, Creating and Maintaining Product Labels and Labeling Records

    Manufacturing and Quality Assurance Professionals responsible for labeling content, format and management

    IT Professionals involved in the conversion of label content formats for electronic labels

    Quality Assurance Personnel

    Auditors engaged in the internal inspection of labeling records and practices

    Consultants working in the life sciences industries responsible for assisting companies with FDA and EMA compliance for labeling content, format and management

    Speaker Profile:

    Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.

    During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.

    For more detail please click on this below link:

    http://bit.ly/2kJHygG

    Email: referralsatcomplianceglobal.us

    Toll Free: +1-844-746-4244

    Tel: +1-516-900-5515

    Fax: +1-516-900-5510


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.